Article

Ophthalmology Times September 15, 2009

Fully searchable access to the September 15, 2009 issue

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
May 22nd 2025

Genentech’s Susvimo receives new FDA indication for diabetic retinopathy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
May 22nd 2025

FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Q&A: Matthew Starr, MD, shares insights into RHONE-X trial
May 22nd 2025

Q&A: Matthew Starr, MD, shares insights into RHONE-X trial

FDA grants Breakthrough Therapy Designation for Tinlarebant
May 21st 2025

FDA grants Breakthrough Therapy Designation for Tinlarebant

© 2025 MJH Life Sciences

All rights reserved.